MENU
STOK
AS OF
Dec 12 closing price
Price
$32.39
Change
-$0.70 (-2.12%)
Capitalization
1.85B
87 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
STOK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Stoke Therapeutics (STOK) Ownership - Who owns Stoke Therapeutics?

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.85B
P/E Ratio
47.63
Total Cash
248.31M
Projected Growth
N/A
Total Debt
2.91M
Revenue
205.63M
Risk (Beta)
2.00
Dividend Yield
N/A
Total Cash/Share
4.35
Total Debt/Equity
N/A
Revenue/Share
3.45 USD as % of share price

Fundamentals

STOK
Capitalization
1.85B
P/E Ratio
47.63
Risk (Beta)
2.00
Dividend Yield
N/A
Total Cash
248M
Total Cash/Share
4.35
Total Debt
2.91M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.45%
Revenue
206M
ROE
N/A
Book Value
308M
P/B Ratio
6.01
Cash Flow
N/A
Earnings
0.71
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
6.53
Current Revenue Per Employee
83062.50
Dividends Per Share - Security
N/A
EBITDA
29.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
12.41
Shares Held By Institutions
2.06B
Shares Outstanding - Current
57.1M
Total Liabilities
52.2M
Total Volume MTD
N/A
Value
-1
Gain YTD
200.000
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
STOK
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. STOK showed earnings on November 04, 2025. You can read more about the earnings report here.
View AI-Driven Trading for STOK
A.I. Advisor
published General Information

General Information

a company, which engages in the research and development of treatments for genetic diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com